Abbott Laboratories Long Term Debt 2010-2024 | ABT

Abbott Laboratories long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
  • Abbott Laboratories long term debt for the quarter ending December 31, 2024 was $12.625B, a 7.16% decline year-over-year.
  • Abbott Laboratories long term debt for 2024 was $12.625B, a 7.16% decline from 2023.
  • Abbott Laboratories long term debt for 2023 was $13.599B, a 6.36% decline from 2022.
  • Abbott Laboratories long term debt for 2022 was $14.522B, a 16.04% decline from 2021.
Abbott Laboratories Annual Long Term Debt
(Millions of US $)
2024 $12,625
2023 $13,599
2022 $14,522
2021 $17,296
2020 $18,527
2019 $16,661
2018 $19,359
2017 $27,210
2016 $20,681
2015 $5,871
2014 $3,393
2013 $3,388
2012 $18,085
2011 $12,040
2010 $12,524
2009 $11,266
Abbott Laboratories Quarterly Long Term Debt
(Millions of US $)
2024-12-31 $12,625
2024-09-30 $12,825
2024-06-30 $13,139
2024-03-31 $12,576
2023-12-31 $13,599
2023-09-30 $14,477
2023-06-30 $14,562
2023-03-31 $14,615
2022-12-31 $14,522
2022-09-30 $15,297
2022-06-30 $16,755
2022-03-31 $17,086
2021-12-31 $17,296
2021-09-30 $17,446
2021-06-30 $17,547
2021-03-31 $17,489
2020-12-31 $18,527
2020-09-30 $18,349
2020-06-30 $18,184
2020-03-31 $16,804
2019-12-31 $16,661
2019-09-30 $17,639
2019-06-30 $18,982
2019-03-31 $18,845
2018-12-31 $19,359
2018-09-30 $19,284
2018-06-30 $19,823
2018-03-31 $21,154
2017-12-31 $27,210
2017-09-30 $23,310
2017-06-30 $23,810
2017-03-31 $23,764
2016-12-31 $20,681
2016-09-30 $5,975
2016-06-30 $6,016
2016-03-31 $5,977
2015-12-31 $5,871
2015-09-30 $5,953
2015-06-30 $5,862
2015-03-31 $5,931
2014-12-31 $3,393
2014-09-30 $3,719
2014-06-30 $3,403
2014-03-31 $3,387
2013-12-31 $3,388
2013-09-30 $3,403
2013-06-30 $3,411
2013-03-31 $3,467
2012-12-31 $18,085
2012-09-30 $12,055
2012-06-30 $12,004
2012-03-31 $11,862
2011-12-31 $12,040
2011-09-30 $13,097
2011-06-30 $12,628
2011-03-31 $12,530
2010-12-31 $12,524
2010-09-30 $12,911
2010-06-30 $12,613
2010-03-31 $10,879
2009-12-31 $11,266
2009-09-30 $11,577
2009-06-30 $11,372
2009-03-31 $11,676
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $230.058B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $149.209B 40.19
Stryker (SYK) United States $142.084B 30.54
EssilorLuxottica (ESLOY) France $131.854B 0.00
Medtronic (MDT) Ireland $115.249B 16.83
Haleon (HLN) United Kingdom $46.488B 26.39
Lonza Group Ag (LZAGY) Switzerland $44.527B 0.00
GE HealthCare Technologies (GEHC) United States $36.909B 17.98
Agilent Technologies (A) United States $33.351B 22.03
ResMed (RMD) United States $32.876B 25.32
Terumo (TRUMY) Japan $27.805B 39.54
Koninklijke Philips (PHG) Netherlands $23.874B 17.05
Zimmer Biomet Holdings (ZBH) United States $22.530B 14.15
Insulet (PODD) United States $18.442B 78.86
Baxter (BAX) United States $17.557B 12.63
Sunny Optical Technology (SNPTF) China $12.864B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $12.403B 0.00
Demant (WILYY) Denmark $8.048B 0.00
Bio-Rad Laboratories (BIO) United States $6.822B 23.62
Lantheus Holdings (LNTH) United States $6.684B 16.43
Prestige Consumer Healthcare (PBH) United States $4.259B 20.32
Perrigo (PRGO) Ireland $3.826B 10.95
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.405B 29.11
Haemonetics (HAE) United States $3.193B 15.02
Envista Holdings (NVST) United States $2.972B 23.64
QuidelOrtho (QDEL) United States $2.359B 19.76
GN Store Nord (GNNDY) Denmark $2.336B 15.74
LeMaitre Vascular (LMAT) United States $1.893B 43.25
Neogen (NEOG) United States $1.881B 21.67
AtriCure (ATRC) United States $1.577B 0.00
AdaptHealth (AHCO) United States $1.462B 14.08
Kestra Medical Technologies (KMTS) $1.234B 0.00
InMode (INMD) Israel $1.234B 10.31
Green Thumb Industries (GTBIF) United States $1.233B 19.37
BioLife Solutions (BLFS) United States $1.073B 0.00
Phibro Animal Health (PAHC) United States $0.865B 13.27
Evolus (EOLS) United States $0.765B 0.00
Owens & Minor (OMI) United States $0.698B 5.94
CeriBell (CBLL) United States $0.689B 0.00
Curaleaf Holdings (CURLF) Canada $0.601B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.562B 0.00
Valneva SE (VALN) France $0.545B 0.00
VAREX IMAGING (VREX) United States $0.478B 20.71
Omeros (OMER) United States $0.476B 0.00
Surmodics (SRDX) United States $0.436B 0.00
Capricor Therapeutics (CAPR) United States $0.433B 0.00
SNDL (SNDL) Canada $0.371B 0.00
Cresco Labs (CRLBF) United States $0.354B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Sanuwave Health (SNWV) United States $0.302B 0.00
ZimVie (ZIMV) United States $0.301B 18.00
Viemed Healthcare (VMD) United States $0.288B 26.00
Sanara MedTech (SMTI) United States $0.275B 0.00
Cerus (CERS) United States $0.258B 0.00
Quanterix (QTRX) United States $0.252B 0.00
OraSure Technologies (OSUR) United States $0.252B 0.00
Aurora Cannabis (ACB) Canada $0.247B 43.90
Verano Holdings (VRNOF) United States $0.233B 0.00
Utah Medical Products (UTMD) United States $0.184B 14.19
Biote (BTMD) United States $0.182B 4.16
Brainsway (BWAY) Israel $0.178B 55.71
TriSalus Life Sciences (TLSI) United States $0.168B 0.00
High Tide (HITI) Canada $0.153B 0.00
Canopy Growth (CGC) Canada $0.144B 0.00
TerrAscend (TSNDF) Canada $0.140B 0.00
Organigram Holdings (OGI) Canada $0.128B 0.00
Jin Medical (ZJYL) China $0.116B 0.00
FitLife Brands (FTLF) United States $0.112B 13.99
Quipt Home Medical (QIPT) United States $0.100B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Fonar (FONR) United States $0.087B 12.18
MacroGenics (MGNX) United States $0.080B 0.00
Veru (VERU) United States $0.072B 0.00
Zynex (ZYXI) United States $0.067B 24.44
United Health Products (UEEC) United States $0.066B 0.00
Exagen (XGN) United States $0.064B 0.00
InterCure (INCR) Israel $0.064B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Cytosorbents (CTSO) United States $0.055B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
Modular Medical (MODD) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
United-Guardian (UG) United States $0.041B 12.66
Rockwell Medical (RMTI) United States $0.038B 56.50
Safety Shot (SHOT) United States $0.027B 0.00
INLIF (INLF) $0.021B 0.00
Nephros (NEPH) United States $0.018B 0.00
Allurion Technologies (ALUR) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00